| Produce Name: | Dasatinib Powder |
|---|---|
| Keywords: | Dasatinib |
| Appearance: | White Powder |
| Assay: | 99%Min Dasatinib |
| CAS No.: | 302962-49-8 |
| Molecular Formula: | C22h26cln7o2s |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name | Dasatinib |
| Appearance | White powder |
| Specifications | 98%min by HPLC |
| MOQ | 1kg |
| Delivery Time | 3-6 Working days(By FEDEX, TNT, DHL and so on, door to door service with smooth and safe customs clearance |
| Payment Method | T/T, West Union Alibaba Trade Assurance, etc. |
| Shelf Time | 2Years |
| Storage | Under cool and dry storage condition |
Dasatinib, also formerly BMS-354825, is a cancer treatment drug marketed by Bristol-Myers Squibb and marketed under the name"Sprycel." Dasatinib is a tyrosine kinase inhibitor against the Philadelphia chromosome and Src gene variants and is mainly used in the treatment of chronic myeloid leukemia (imatinib) chronic myelogenous leukemia, and Philadelphia chromosome positive acute myeloid leukemia (Ph + ALL) patients. The drug has also been shown to treat many other types of cancer, including accelerated prostate cancer.
| Product name: | Dasatinib | CAS No.: | 302962-49-8 |
| MF: | C22H26ClN7O2S | MW: | 488.01 |
| Item | Specification |
| Assay | >98% |
| Appearance | White powder |
| Odor | Characteristic |
| Taste | Characteristic |
| Particle Size | NLT 100% Through 80 mesh |
| Loss on Drying | <2.0% |
| Heavy metals | ≤10ppm |
| Arsenic | ≤3ppm |
| Lead | ≤3ppm |
| <2.0% | |
| Total Plate Count | ≤1000cfu/g |
| Total Yeast & Mold | ≤100cfu/g |
| E.Coli | Negative |
| Salmonella | Negative |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}